|
Real-time Estimate
Cboe BZX
13:28:55 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 1.175 USD | +3.07% |
|
0.00% | -13.24% |
| 08-14 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 08-14 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ATNM | Delayed | |
Tradegate
| 7AY1 | Real-time | |
CBOE
| ATNM | Real-time | |
Deutsche Boerse AG
| 7AY1 | Delayed | |
Börse Stuttgart
| 7AY1 | Delayed | |
Boerse Muenchen
| 7AY1 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 1.4 | 1.52 | 1.69 |
| Spread/Res. | -15.36% | -22.04% | -29.88% |
| Spread/Supp. | +19.04% | +58.27% | +48.61% |
| Support | 0.9955 | 0.7487 | 0.7974 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ATNM Stock
- Charts Actinium Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions

















